Agree a Great Company, and like many it doesn’t deserve to be in this current position, but unlike many its Balance Sheet should give it more resilience to get thro so one to hang onto, plus a Nation can live without a lot of things but not food !
Fully expect this to retrace tomorrow pm unless of course GB blows the “bloody doors off“ as he may well, but irrespective this has legs to go much further just on what is currently known, so for me this is a firm hold.
Personally wouldn’t worry too much over combined Mkt Value at present as there’s a very good story unfolding here, and of course revenue is being earnt. SYME is a similar story but look at its Mkt Cap. with revenue yet to really kick in. Sentiment & good news on Thursday could really drive this higher quite quickly.
Anyone thinking of selling out short term may first wish to ponder on GB’s vision... “He has a five-year plan to grow Integumen before selling it on. His previous public company, Alltracel Pharmaceuticals, sold for $55m in 2008. He expects to make substantially more from Integumen.“ Per Yorkshire Post interview today.
Chesh....within the MW Offer Notes “The Offer Document, together with the relevant Forms of Acceptance, will be sent to Modern Water Shareholders in due course and in any event by no later than 25 September 2020 “ .
Problem being it’s cheap as chips for a reason. The CEO seems to be taking the easy route of shrinking the Company realising its currently worth more in bits than in whole and turning her back on some real growth opportunities such as Asia,. Yes it will plod along but there’s no dynamism here. Good luck on her pinning hopes that the UK will deliver the goods, its economy doesn’t look in the best of health right now !
‘ Is the virus losing its potency’ ? Well the Lancet Journal certainly believes so and to the extent that Lockdown impedes it’s natural weakening, but that narrative isn’t welcomed by the Govnt shown by their fixation on highlighting new cases and not actual deaths , which plateaued sometime ago. Anyway it’s in shareholders interest to support such scaremongering so for me Matt Han**** is doing a brilliant job !
RE: Two RNS next week for Skin/DVRG according the Gerry Brandon!19 Sep 2020 19:49
Agree, you can’t have a CEO of a Public Company giving out forward notice of RNS releases on Social Media, irrespective of the pressure Impatient investors apply. That said GB is always very supportive in helping investors understand his Company’s endeavours so will put this one down to his helpful enthusiasm.
Well as CEO of a Company which is being called a fake and who should be imprisoned , I’d be taking legal action for defamation ( libel) as otherwise TW will just naw away as is his trade mark. Not the most pleasant of individuals.
Hopefully at some point the Government will have a clear “testing” strategy . Currently MH seems of the opinion only those currently showing signs of infection need testing, which is not quite what BJ seems to have in mind . No doubt Sunak will also have an opinion. Per the Times today.... “Matt Han**** blamed people without symptoms for causing a testing shortage by getting needless checks, saying there was a need to be “firmer” about eligibility rules. He said it was “not acceptable” for people to book a test because they were going on holiday or for schools to send whole classes for checks. A sharp rise in demand from people with no symptoms meant those who were ill were being told to drive hundreds of miles to be tested, he said.
The French Connection could be this . “ A revolutionary test called EasyCov was developed in less than three months by the Sys2Diag laboratory in Montpellier...this test is similar in ways to a pregnancy test. The colour of a saliva-soaked tablet will indicate whether or not virus antibodies are present without any need to go to a laboratory for analysis” Not quite what Avct are working on though.
RK......I suspect many Investors are only interested in making a quick buck on the back of its LFT and thus get slightly disappointed whenever a new RNS gets a muted response from the Market. As LTH’s daily price movements are academic, I’m equally pleased to be an investor in such a UK success story, but as my investments are held in trust for others I can afford to be relaxed !